# Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis

> **NCT01569984** · PHASE2 · COMPLETED · sponsor: **Dr. Yoo-Joung Ko** · enrollment: 11 (actual)

## Conditions studied

- Colorectal Cancer.

## Interventions

- **RADIATION:** Stereotactic body radiotherapy

## Key facts

- **NCT ID:** NCT01569984
- **Lead sponsor:** Dr. Yoo-Joung Ko
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01569984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01569984, "Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01569984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*